These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 3536232)

  • 1. Vitamin D Analogues and Fracture Risk in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Khelifi N; Desbiens LC; Sidibé A; Mac-Way F
    JBMR Plus; 2022 Apr; 6(4):e10611. PubMed ID: 35434454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone responsiveness to parathyroid hormone is negatively associated with parathyroid hormone-lowering drug use in patients undergoing hemodialysis: a cross-sectional study.
    Tominaga N; Yonaha T; Yamanouchi M; Sumi H; Taki Y; Shibagaki Y; Shiizaki K; Yano S
    BMC Nephrol; 2021 Aug; 22(1):275. PubMed ID: 34372813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Old and New Drugs for the Management of Bone Disorders in CKD.
    Komaba H; Ketteler M; Cunningham J; Fukagawa M
    Calcif Tissue Int; 2021 Apr; 108(4):486-495. PubMed ID: 33386480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D, a modulator of musculoskeletal health in chronic kidney disease.
    Molina P; Carrero JJ; Bover J; Chauveau P; Mazzaferro S; Torres PU;
    J Cachexia Sarcopenia Muscle; 2017 Oct; 8(5):686-701. PubMed ID: 28675610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of bone in CKD-mediated mineral and vascular disease.
    Khouzam NM; Wesseling-Perry K; Salusky IB
    Pediatr Nephrol; 2015 Sep; 30(9):1379-88. PubMed ID: 25168424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D and chronic kidney disease-mineral bone disease (CKD-MBD).
    Nigwekar SU; Tamez H; Thadhani RI
    Bonekey Rep; 2014; 3():498. PubMed ID: 24605215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renale osteodystrophie.
    Cejka D
    Wien Med Wochenschr; 2013 Sep; 163(17-18):403-8. PubMed ID: 23657637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphate binders, vitamin D and calcimimetics in the management of chronic kidney disease-mineral bone disorders (CKD-MBD) in children.
    Wesseling-Perry K; Salusky IB
    Pediatr Nephrol; 2013 Apr; 28(4):617-25. PubMed ID: 23381010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D therapy in chronic kidney disease and end stage renal disease.
    Melamed ML; Thadhani RI
    Clin J Am Soc Nephrol; 2012 Feb; 7(2):358-65. PubMed ID: 22193236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oral calcitriol pulse therapy in hemodialysis patients. Effects on histomorphometry of bone in renal hyperparathyroidism].
    Sperschneider H; Humbsch K; Abendroth K
    Med Klin (Munich); 1997 Oct; 92(10):597-603. PubMed ID: 9446007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination.
    Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Eade Y; Johnson JR; George CR; Collett P
    Miner Electrolyte Metab; 1985; 11(6):358-68. PubMed ID: 3877862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.
    Ogata H; Koiwa F; Shishido K; Takahashi K; Ito H; Kinugasa E; Taguchi S
    Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dialysis osteomalacia: clinical aspects and physiopathological mechanisms.
    Drüeke T; Cournot-Witmer G
    Clin Nephrol; 1985; 24 Suppl 1():S26-9. PubMed ID: 3915957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled trial of calcitriol in hemodialysis patients.
    Baker LR; Muir JW; Sharman VL; Abrams SM; Greenwood RN; Cattell WR; Goodwin FJ; Marsh FP; Adami S; Hately W
    Clin Nephrol; 1986 Oct; 26(4):185-91. PubMed ID: 3536232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled trial of calcitriol in the prevention of bone disease in haemodialysed patients.
    Sharman VL; Abrams SM; Adami S; Cattell WR; Chaput de Saintonge DM; Greenwood RN; Goodwin FJ; Hately W; Hattersley LA; Marsh FP; Morgan AG; Muir JW; O'Riordan JL; Papapoulos SE; Revell P; Tucker AK; Baker LR
    Proc Eur Dial Transplant Assoc; 1983; 19():287-92. PubMed ID: 6348740
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.